These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3516541)

  • 21. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of letosteine in the treatment of sputum thickening and expectoration difficulty in patients with respiratory diseases: a multicenter, randomized, double-masked, double dummy, positive drug parallel controlled trial.
    Zhou Y; Sun S; Liu H; Cui L; Chang X; Sun Z
    Pharmazie; 2014 Nov; 69(11):842-9. PubMed ID: 25985582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical trial of bromhexine.
    Thompson KJ; Reeve J
    N Z Med J; 1972 Aug; 76(483):73-6. PubMed ID: 4264310
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long term treatment with biosolvonamid].
    Höhfeld HH
    Med Monatsschr; 1968 Sep; 22(9):411-4. PubMed ID: 5702822
    [No Abstract]   [Full Text] [Related]  

  • 25. [Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience].
    Romano C; Gargani GF; Minicucci L; Nantron M
    Minerva Pediatr; 1984 Feb; 36(3):127-38. PubMed ID: 6374414
    [No Abstract]   [Full Text] [Related]  

  • 26. Rheological modifications of mucus in chronic bronchitic patients after treatment with stepronine-lysine salt.
    Braga PC; Bossi R; Allegra L
    Drugs Exp Clin Res; 1987; 13(11):707-10. PubMed ID: 3443046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Criteria of drug testing in industrial practice, demonstrated by a cough remedy].
    Nesswetha W
    Arzneimittelforschung; 1967 Oct; 17(10):1324-6. PubMed ID: 4885305
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical evaluation of the therapeutic efficacy of a new antiphlogistic and mucus-regulating drug, guaimesal, in acute and chronic bronchopneumopathies].
    Bandera M; Fioretti M
    Clin Ter; 1984 Sep; 110(5):455-61. PubMed ID: 6238760
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anomalies of mucus and bronchial pathology in adults].
    Polu JM; Delorme N
    Rev Mal Respir; 1989; 6(6):493-9. PubMed ID: 2690213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The parenteral use of a derivative of benzylamine in the control of tracheobronchial patological secretions].
    Bianchetti L; Chiri A
    Minerva Med; 1969 Sep; 60(75):3521-4. PubMed ID: 5344812
    [No Abstract]   [Full Text] [Related]  

  • 31. [Association of bronchodilator agents and mucolytics in aerosol therapy of chronic bronchopathies].
    Olivieri D; Brancaccio L; Bocchino M
    Handchirurgie; 1974; 29(2):138-46. PubMed ID: 4452486
    [No Abstract]   [Full Text] [Related]  

  • 32. [Possibilities of the use in the tracheo-bronchial hypersecretion syndrome of a muco-fluidifying compound].
    Alinei D; Alinei E
    Ann Laringol Otol Rinol Faringol; 1976; 75(3-4):275-80. PubMed ID: 1037661
    [No Abstract]   [Full Text] [Related]  

  • 33. Double-blind clinical trial of domiodol vs S-carboxymethylcysteine in chronic obstructive lung disease.
    Casali L; Rampulla C; Rossi A
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):554-7. PubMed ID: 6757153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modifiers of bronchial secretions in the asthmatic patient].
    Medici TC; Radielovic P
    Allergol Immunopathol (Madr); 1981; Suppl 9():201-6. PubMed ID: 7349729
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical trial with CO-1177: a preliminary report.
    Mbuyamba P
    Int J Clin Pharmacol Res; 1986; 6(2):119-21. PubMed ID: 3522442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bisolvon in the treatment of the tracheo-bronchial secretory syndrome of the laryngectomized].
    Ameli M
    Minerva Med; 1969 Sep; 60(75):3503-8. PubMed ID: 5344810
    [No Abstract]   [Full Text] [Related]  

  • 37. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of a broncho-secretolytic in lung specialties with the help of a simple measuring method].
    Wilde W
    Arztl Forsch; 1966 Mar; 20(3):149-56. PubMed ID: 6014420
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bronchopulmonary diseases in advanced age. Therapy using Expectorans Solucampher].
    Boecker M
    ZFA (Stuttgart); 1979 Feb; 55(6):400-2. PubMed ID: 419831
    [No Abstract]   [Full Text] [Related]  

  • 40. Disposition and metabolism of letosteine in rats.
    Gachon F; Nicolas C; Maurizis JC; Verny M; Chabard JL; Faurie M; Gaillard G
    Drug Metab Dispos; 1988; 16(6):853-7. PubMed ID: 2907465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.